Biomax announces early adopter program for NeuroXM June 14, 2018June 18, 2018 by / Share This.....LinkedinTwitterFacebookGoogleEmailhttps://www.biomax.com/lib/press-releases/201806_NeuroXM.pdf Related News: Xylem Invests $20M in Venture Capital Funds to…CHMP recommends EU approval of Roche’s Tecentriq as…European Commission approves Roche’s Tecentriq as…Eight-year data from APHINITY study show Roche’s…Early treatment with Roche's OCREVUS leads to…[Ad hoc announcement pursuant to Art. 53 LR] Roche…
